Direkt zum Inhalt

Spitzer, Martin S. ; Yoeruek, Efdal ; Sierra, Ana ; Wallenfels-Thilo, Barbara ; Schraermeyer, Ulrich ; Spitzer, Bernhard ; Bartz-Schmidt, Karl U. ; Szurman, Peter

Comparative antiproliferative and cytotoxic profile of bevacizumab (Avastin), pegaptanib (Macugen) and ranibizumab (Lucentis) on different ocular cells

Article

Spitzer, Martin S. , Yoeruek, Efdal, Sierra, Ana, Wallenfels-Thilo, Barbara, Schraermeyer, Ulrich, Spitzer, Bernhard , Bartz-Schmidt, Karl U. and Szurman, Peter (2007) Comparative antiproliferative and cytotoxic profile of bevacizumab (Avastin), pegaptanib (Macugen) and ranibizumab (Lucentis) on different ocular cells. Graefe's Archive for Clinical and Experimental Ophthalmology 245 (12), pp. 1837-1842.



Involved Institutions


Details

Item typeArticle
Journal or Publication TitleGraefe's Archive for Clinical and Experimental Ophthalmology
PublisherSPRINGER
Place of PublicationNEW YORK
Volume245
Number of Issue or Book Chapter12
Page Rangepp. 1837-1842
Date2007
Date of publication19 Dec 2024 13:34
InstitutionsHuman Sciences > Institut für Psychologie
Identification Number
ValueType
10.1007/s00417-007-0568-7DOI
KeywordsENDOTHELIAL GROWTH-FACTOR; MACULAR DEGENERATION; DISEASE; bevacizumab (Avastin); pegaptanib (Macugen); ranibizumab (Lucentis); ocular cells; antiproliferative
Dewey Decimal Classification100 Philosophy & psychology > 150 Psychology
StatusPublished
RefereedYes, this version has been refereed
Created at the University of RegensburgYes
Item ID68656

Export bibliographical data

Owner only: item control page

nach oben